What is the ticker symbol for Cytokinetics, Incorporated?

The ticker symbol for Cytokinetics, Incorporated is NASDAQ:CYTK

Does Cytokinetics, Incorporated pay dividends?

No, Cytokinetics, Incorporated does not pay dividends

What sector is Cytokinetics, Incorporated in?

Cytokinetics, Incorporated is in the Healthcare sector

What industry is Cytokinetics, Incorporated in?

Cytokinetics, Incorporated is in the Biotechnology industry

What country is Cytokinetics, Incorporated based in?

Cytokinetics, Incorporated is headquartered in United States

When did Cytokinetics, Incorporated go public?

Cytokinetics, Incorporated initial public offering (IPO) was on April 26, 2004

Is Cytokinetics, Incorporated in the S&P 500?

No, Cytokinetics, Incorporated is not included in the S&P 500 index

Is Cytokinetics, Incorporated in the NASDAQ 100?

No, Cytokinetics, Incorporated is not included in the NASDAQ 100 index

Is Cytokinetics, Incorporated in the Dow Jones?

No, Cytokinetics, Incorporated is not included in the Dow Jones index

When was Cytokinetics, Incorporated last earnings report?

Cytokinetics, Incorporated's most recent earnings report was on August 6, 2026

When does Cytokinetics, Incorporated report earnings?

The next expected earnings date for Cytokinetics, Incorporated is November 5, 2026

CYTK Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, CYTK price is $72.45, down -1.79% on September 14, 2026
Current Price All-Time High: CYTK price is currently -34.29% below its historical high of $110.25 set on January 8, 2024
Market Cap: CYTK current market cap is $10B, up +70.33% over the past 365 days
Revenue: CYTK current annual revenue is $88.04M, up +376.56% year-over-year
Next Earnings: The next earnings release for CYTK is on November 5, 2026

Profile

Company profile for Cytokinetics, Incorporated (CYTK)
Metric	Value
Full Name	Cytokinetics, Incorporated
Ticker	NASDAQ: CYTK
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Apr 26, 2004
Indexes	Not included
Website	cytokinetics.com
Employees	498

Key Metrics

Cytokinetics, Incorporated Key Details
Metric	Value	Date
Price	$72.45	Sep 14, 26
Price, 1D Change	-1.79%	Sep 14, 26
Market Cap	$10B	Sep 14, 26
	-	Sep 14, 26
PE Ratio	-	Sep 14, 26
Beta	0.89	Sep 14, 26
Revenue	$88.04M	Dec 31, 25
Revenue, 1Y Change	+376.56%	Dec 31, 25
EPS	-$6.54	Dec 31, 25
EPS, 1Y Change	-24.14%	Dec 31, 25

Events

Cytokinetics, Incorporated Events
Metric	Value	Date
Next Earnings		Nov 5, 26
Last Qtr. Earnings		Aug 6, 26
Last Ann. Earnings		Feb 24, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	1:6	Jun 25, 13
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

CYTK Estimates
Metric	Value	Date
EPS	-$6.54	Dec 31, 25
EPS Estimate	-$5.94	N/A
EPS Est. Change	+9.04%	N/A
Revenue	$88.04M	Dec 31, 25
Revenue Estimate	$149.77M	N/A
Revenue Est. Change	+70.12%	N/A
Current Price	$72.45	Sep 14, 26
Price Target	$107.50	-
Price Tgt. Change	+48.38%	-

🔒 Log In To Unlock Full Data

EPS

CYTK EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	-$5.16	-$5.26	-1.98%
2025	-$6.22	-$6.54	-5.04%
2026	-$5.94	N/A	+9.04%
2027	-$4.45	N/A	+31.88%

Revenue

CYTK revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$14.37M	$18.47M	+28.55%
2025	$81.03M	$88.04M	+8.65%
2026	$149.77M	N/A	+70.12%
2027	$424.81M	N/A	+382.52%

🔒 Log In To Unlock Full Data

Performance

CYTK Performance
Metric	Value	Date
Price, 1Y	+46.54%	Sep 14, 26
Price, 3Y	+111.66%	Sep 14, 26
Market Cap, 1Y	+70.33%	Sep 14, 26
Market Cap, 3Y	+206.71%	Sep 14, 26
Revenue, 1Y	+376.56%	Dec 31, 25
Revenue, 3Y	-6.92%	Dec 31, 25
EPS, 1Y	-24.14%	Dec 31, 25
EPS, 3Y	-50.94%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

CYTK Technical Indicators
Metric	Value	Date
Current Price	$72.45	Sep 14, 26
SMA 200	$69.97	Sep 14, 26
SMA 50	$78.04	Sep 14, 26
EMA 200	$69.80	Sep 14, 26
EMA 50	$76.03	Sep 14, 26
MACD	-$1.24	Sep 14, 26
Beta	0.89	Sep 14, 26
ATR	$2.65	Sep 14, 26
14-Day RSI	41.88	Sep 14, 26
10-Day Volatility	30.78%	Sep 14, 26

Dividends

CYTK Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Sep 14, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

CYTK Income & Profitability
Metric	Value	Date
Revenue	$88.04M	Dec 31, 25
EPS	-$6.54	Dec 31, 25
Gross Profit	$0.00	Dec 31, 25
Gross Margin	88.50%	Dec 31, 25
Operating Income	-$612.26M	Dec 31, 25
Operating Margin	-695.44%	Dec 31, 25
Net Income	-$784.96M	Dec 31, 25
Net Margin	-891.60%	Dec 31, 25
EBITDA	-$602.13M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

CYTK Financial Health
Metric	Value	Date
Debt To Equity	-1.95	Dec 31, 25
	4.53	Dec 31, 25
	4.53	Dec 31, 25
	-	Dec 31, 25
	1	Jun 30, 26
	-1.28	Sep 14, 26

Valuations

CYTK Valuations
Metric	Value	Date
PE Ratio	-	Sep 14, 26
	148.84	Sep 14, 26
	-58.06	Sep 14, 26
	-14.63	Sep 14, 26
	-	N/A

Balance Sheet

CYTK Balance Sheet
Metric	Value	Date
Book Value	-$659.62M	Dec 31, 25
	$885.34M	Dec 31, 25
	$1.42B	Dec 31, 25
	$916.98M	Dec 31, 25
	$2.08B	Dec 31, 25
	$202.45M	Dec 31, 25
Total Debt	$1.28B	Dec 31, 25
	$60.29M	Dec 31, 25
	$22.34M	Dec 31, 25

Expenses

CYTK Expenses
Metric	Value	Date
	$872.99M	Dec 31, 25
	$612.26M	Dec 31, 25
	$10.13M	Dec 31, 25
	$0.00	Dec 31, 25
	$10.13M	Dec 31, 25
	$0.00	Dec 31, 25
	$0.00	Dec 31, 25

Cash Flow

CYTK Cash Flow
Metric	Value	Date
	-$510.01M	Dec 31, 25
	$16.67M	Dec 31, 25
	$524.46M	Dec 31, 25
Capex	$24.81M	Dec 31, 25
	-$534.82M	Dec 31, 25

Recent analyst updates

CYTK Recent analyst updates
Metric	Value	Date
HC Wainwright & Co.	→	Aug 31, 26
JP Morgan	→	Aug 13, 26
Barclays	→	Aug 13, 26
Truist Securities	→	Aug 10, 26
RBC Capital	→	Aug 7, 26
Needham	→	Aug 7, 26
Citizens	→	Aug 7, 26
RBC Capital	→	Jul 7, 26
UBS	→	Jun 29, 26
Mizuho	→	Jun 24, 26

Analyst sentiment

Institutional ownership

No data

Screeners with CYTK

FAQ

What is the ticker symbol for Cytokinetics, Incorporated?: The ticker symbol for Cytokinetics, Incorporated is NASDAQ:CYTK
Does Cytokinetics, Incorporated pay dividends?: No, Cytokinetics, Incorporated does not pay dividends
What sector is Cytokinetics, Incorporated in?: Cytokinetics, Incorporated is in the Healthcare sector
What industry is Cytokinetics, Incorporated in?: Cytokinetics, Incorporated is in the Biotechnology industry
What country is Cytokinetics, Incorporated based in?: Cytokinetics, Incorporated is headquartered in United States
When did Cytokinetics, Incorporated go public?: Cytokinetics, Incorporated initial public offering (IPO) was on April 26, 2004
Is Cytokinetics, Incorporated in the S&P 500?: No, Cytokinetics, Incorporated is not included in the S&P 500 index
Is Cytokinetics, Incorporated in the NASDAQ 100?: No, Cytokinetics, Incorporated is not included in the NASDAQ 100 index
Is Cytokinetics, Incorporated in the Dow Jones?: No, Cytokinetics, Incorporated is not included in the Dow Jones index
When was Cytokinetics, Incorporated last earnings report?: Cytokinetics, Incorporated's most recent earnings report was on August 6, 2026
When does Cytokinetics, Incorporated report earnings?: The next expected earnings date for Cytokinetics, Incorporated is November 5, 2026

Data Sources & References

CYTK Official Website www.cytokinetics.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk